Detalles de la búsqueda
1.
TP53 mutant cell lines selected for resistance to MDM2 inhibitors retain growth inhibition by MAPK pathway inhibitors but a reduced apoptotic response.
Cancer Cell Int
; 19: 53, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30899200
2.
ATM Dependent DUSP6 Modulation of p53 Involved in Synergistic Targeting of MAPK and p53 Pathways with Trametinib and MDM2 Inhibitors in Cutaneous Melanoma.
Cancers (Basel)
; 11(1)2018 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30577494
Resultados
1 -
2
de 2
1
Próxima >
>>